457 related articles for article (PubMed ID: 37016182)
1. Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors.
Sharma S; Rana R; Prakash P; Ganguly NK
Mol Cell Biochem; 2024 Jan; 479(1):127-170. PubMed ID: 37016182
[TBL] [Abstract][Full Text] [Related]
2. [Update Knowledge for Brain Tumors(7)Meningioma].
Kawahara N
No Shinkei Geka; 2016 May; 44(5):415-30. PubMed ID: 27166847
[No Abstract] [Full Text] [Related]
3. Exosome-based Tumor Therapy: Opportunities and Challenges.
Li C; Hou X; Zhang P; Li J; Liu X; Wang Y; Guan Q; Zhou Y
Curr Drug Metab; 2020; 21(5):339-351. PubMed ID: 32410558
[TBL] [Abstract][Full Text] [Related]
4. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
Chamberlain MC
Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
[TBL] [Abstract][Full Text] [Related]
6. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
Rana R; Sharma S; Ganguly NK
Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
[TBL] [Abstract][Full Text] [Related]
8. Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma.
Luo H; Zhang H; Mao J; Cao H; Tao Y; Zhao G; Zhang Z; Zhang N; Liu Z; Zhang J; Luo P; Xia Y; Cheng Y; Xie Z; Cheng Q; Liu G
Cell Death Dis; 2023 Apr; 14(4):235. PubMed ID: 37012233
[TBL] [Abstract][Full Text] [Related]
9. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
[TBL] [Abstract][Full Text] [Related]
10. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
Angus SP; Oblinger JL; Stuhlmiller TJ; DeSouza PA; Beauchamp RL; Witt L; Chen X; Jordan JT; Gilbert TSK; Stemmer-Rachamimov A; Gusella JF; Plotkin SR; Haggarty SJ; Chang LS; Johnson GL; Ramesh V;
Neuro Oncol; 2018 Aug; 20(9):1185-1196. PubMed ID: 29982664
[TBL] [Abstract][Full Text] [Related]
11. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-
Fu XH; Li JP; Li XY; Tan Y; Zhao M; Zhang SF; Wu XD; Xu JG
J Immunol Res; 2022; 2022():8326591. PubMed ID: 35637794
[TBL] [Abstract][Full Text] [Related]
12. Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics.
Yoshikawa A; Nakada M; Ohtsuki S; Hayashi Y; Obuchi W; Sato Y; Ikeda C; Watanabe T; Kawahara Y; Hasegawa T; Sabit H; Kita D; Hayashi Y; Nakanuma Y; Terasaki T; Hamada JI
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):105-10. PubMed ID: 21696419
[No Abstract] [Full Text] [Related]
13. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
14. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
15. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
[TBL] [Abstract][Full Text] [Related]
16. Targeted drug therapy for meningiomas.
Norden AD; Drappatz J; Wen PY
Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies for meningiomas.
Wen PY; Drappatz J
Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
[TBL] [Abstract][Full Text] [Related]
18. mTOR Signaling and Potential Therapeutic Targeting in Meningioma.
Pinker B; Barciszewska AM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216092
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in chemotherapy for meningiomas: a review.
Moazzam AA; Wagle N; Zada G
Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
[TBL] [Abstract][Full Text] [Related]
20. Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.
Skibinski CG; Williamson T; Riggins GJ
J Neurooncol; 2018 Dec; 140(3):529-538. PubMed ID: 30414098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]